CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $74,000 | -43.5% | 13,583 | -68.8% | 0.00% | – |
| Q3 2019 | $131,000 | -29.2% | 43,578 | -12.1% | 0.00% | – |
| Q2 2019 | $185,000 | -2.6% | 49,578 | +4.6% | 0.00% | – |
| Q1 2019 | $190,000 | +9.8% | 47,378 | +0.6% | 0.00% | – |
| Q4 2018 | $173,000 | -56.6% | 47,078 | +1.3% | 0.00% | -100.0% |
| Q3 2018 | $399,000 | -18.7% | 46,478 | +4.0% | 0.00% | 0.0% |
| Q2 2018 | $491,000 | -3.9% | 44,678 | +0.9% | 0.00% | 0.0% |
| Q1 2018 | $511,000 | +293.1% | 44,278 | +312.1% | 0.00% | – |
| Q2 2017 | $130,000 | -73.9% | 10,744 | -55.3% | 0.00% | -100.0% |
| Q1 2017 | $499,000 | +56.9% | 24,049 | +8.1% | 0.00% | 0.0% |
| Q4 2016 | $318,000 | -17.8% | 22,244 | -5.5% | 0.00% | 0.0% |
| Q3 2016 | $387,000 | – | 23,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $4,782,399 | 1.67% |
| TOWERVIEW LLC | 342,478 | $500,018 | 0.33% |
| Orbimed Advisors | 6,943,654 | $10,137,735 | 0.22% |
| SAMLYN CAPITAL, LLC | 2,405,764 | $3,512,415 | 0.06% |
| BVF INC/IL | 1,370,947 | $2,001,583 | 0.05% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $93,109 | 0.04% |
| MYDA Advisors LLC | 68,814 | $100,468 | 0.03% |
| Masso Torrence Wealth Management Inc. | 10,000 | $14,600 | 0.01% |
| Hikari Power Ltd | 49,959 | $73 | 0.01% |
| XTX Topco Ltd | 19,244 | $28,096 | 0.01% |